TR199900725T2 - Hydroxamic acid derivatives - Google Patents
Hydroxamic acid derivativesInfo
- Publication number
- TR199900725T2 TR199900725T2 TR1999/00725T TR9900725T TR199900725T2 TR 199900725 T2 TR199900725 T2 TR 199900725T2 TR 1999/00725 T TR1999/00725 T TR 1999/00725T TR 9900725 T TR9900725 T TR 9900725T TR 199900725 T2 TR199900725 T2 TR 199900725T2
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- hydroxamic acid
- acid derivatives
- novel
- pharmacoticly
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Yeni hidroksamik asit bilesikleri, örnegin formül I'in buradaki R1,R2, R3 ve R4 tanimlandigi gibidir. Sözkonusu bilesiklerin farmakosotik olarak kullanilabilecegi bulunmustur, örnegin TNF yayiminin bastirilmasi, oto immün ve iltihabik hastaliklarin tedavisi, örnegin, muhtelif sklerozlar ve romatizmaya benzer eklem iltihabi. Bilesiklerin, yeni ara ürünlerinin ve bilesileri içeren farmakolojik kompozisyonlarin yapim metodlarini saglar.The novel hydroxamic acid compounds are, for example, as defined in formula I wherein R1, R2, R3 and R4 are defined. These compounds have been found to be used pharmacoticly, eg suppression of TNF release, treatment of auto immune and inflammatory diseases, for example, various sclerosis and joint inflammation similar to rheumatism. It provides methods of making compounds, novel intermediates and pharmacological compositions containing compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9620572.9A GB9620572D0 (en) | 1996-10-02 | 1996-10-02 | Organic compounds |
| GBGB9706667.4A GB9706667D0 (en) | 1997-04-02 | 1997-04-02 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199900725T2 true TR199900725T2 (en) | 1999-07-21 |
Family
ID=26310147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/00725T TR199900725T2 (en) | 1996-10-02 | 1997-09-30 | Hydroxamic acid derivatives |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0929517B1 (en) |
| JP (1) | JP3444898B2 (en) |
| KR (1) | KR20000048811A (en) |
| CN (1) | CN1101807C (en) |
| AR (1) | AR009103A1 (en) |
| AT (1) | ATE219050T1 (en) |
| AU (1) | AU726065B2 (en) |
| BR (1) | BR9712255A (en) |
| CA (1) | CA2267415A1 (en) |
| CO (1) | CO4900034A1 (en) |
| CZ (1) | CZ113999A3 (en) |
| DE (1) | DE69713354T2 (en) |
| DK (1) | DK0929517T3 (en) |
| ES (1) | ES2178759T3 (en) |
| HK (1) | HK1021637A1 (en) |
| HU (1) | HUP9903892A3 (en) |
| ID (1) | ID22212A (en) |
| IL (1) | IL129166A0 (en) |
| MY (1) | MY127926A (en) |
| NO (1) | NO313457B1 (en) |
| NZ (1) | NZ334908A (en) |
| PE (1) | PE2099A1 (en) |
| PL (1) | PL188518B1 (en) |
| PT (1) | PT929517E (en) |
| RU (1) | RU2196131C2 (en) |
| SI (1) | SI0929517T1 (en) |
| SK (1) | SK43099A3 (en) |
| TR (1) | TR199900725T2 (en) |
| WO (1) | WO1998014424A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004056353A2 (en) * | 2002-12-20 | 2004-07-08 | Novartis Ag | Device and method for delivering mmp inhibitors |
| CA2534352A1 (en) | 2003-08-08 | 2005-02-17 | Arriva Pharmaceuticals, Inc. | Methods of protein production in yeast |
| JP2007528409A (en) | 2004-03-09 | 2007-10-11 | アリバ ファーマシューティカルズ， インコーポレイテッド | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitors |
| CN1951912B (en) * | 2005-10-18 | 2010-05-05 | 上海五洲药业股份有限公司 | Chiral alicyclic hydrocarbon hydroxamic acid derivative preparation method |
| GB0818907D0 (en) * | 2008-10-15 | 2008-11-19 | Isis Innovation | Histone lysine demethylase inhibitors |
| ES2903079T3 (en) * | 2016-04-18 | 2022-03-31 | Vivoryon Therapeutics N V | Novel alpha and beta meprin inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
| PL179997B1 (en) * | 1994-01-20 | 2000-11-30 | British Biotech Pharm | Inhibitors of metalloproteinases |
| HUT74511A (en) * | 1994-01-22 | 1997-01-28 | British Biotech Pharm | Metalloproteinase inhibitors, pharmaceutical compns. contg. them and process to prepare the said compds. |
| GB9416897D0 (en) * | 1994-08-20 | 1994-10-12 | British Biotech Pharm | Metalloproteinase inhibitors |
| GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
-
1997
- 1997-09-30 PT PT97909339T patent/PT929517E/en unknown
- 1997-09-30 KR KR1019990702806A patent/KR20000048811A/en not_active Application Discontinuation
- 1997-09-30 JP JP51623698A patent/JP3444898B2/en not_active Expired - Fee Related
- 1997-09-30 WO PCT/EP1997/005376 patent/WO1998014424A1/en not_active Application Discontinuation
- 1997-09-30 AR ARP970104491A patent/AR009103A1/en unknown
- 1997-09-30 CA CA002267415A patent/CA2267415A1/en not_active Abandoned
- 1997-09-30 RU RU99108792/04A patent/RU2196131C2/en not_active IP Right Cessation
- 1997-09-30 TR TR1999/00725T patent/TR199900725T2/en unknown
- 1997-09-30 SI SI9730357T patent/SI0929517T1/en unknown
- 1997-09-30 EP EP97909339A patent/EP0929517B1/en not_active Expired - Lifetime
- 1997-09-30 IL IL12916697A patent/IL129166A0/en not_active IP Right Cessation
- 1997-09-30 SK SK430-99A patent/SK43099A3/en unknown
- 1997-09-30 NZ NZ334908A patent/NZ334908A/en unknown
- 1997-09-30 CN CN97198511A patent/CN1101807C/en not_active Expired - Fee Related
- 1997-09-30 BR BR9712255A patent/BR9712255A/en not_active Application Discontinuation
- 1997-09-30 AU AU47068/97A patent/AU726065B2/en not_active Ceased
- 1997-09-30 DE DE69713354T patent/DE69713354T2/en not_active Expired - Lifetime
- 1997-09-30 PL PL97332477A patent/PL188518B1/en not_active IP Right Cessation
- 1997-09-30 PE PE1997000874A patent/PE2099A1/en not_active Application Discontinuation
- 1997-09-30 DK DK97909339T patent/DK0929517T3/en active
- 1997-09-30 AT AT97909339T patent/ATE219050T1/en not_active IP Right Cessation
- 1997-09-30 ES ES97909339T patent/ES2178759T3/en not_active Expired - Lifetime
- 1997-09-30 HU HU9903892A patent/HUP9903892A3/en unknown
- 1997-09-30 ID IDW990143D patent/ID22212A/en unknown
- 1997-09-30 CZ CZ991139A patent/CZ113999A3/en unknown
- 1997-10-01 CO CO97057298A patent/CO4900034A1/en unknown
- 1997-10-01 MY MYPI97004587A patent/MY127926A/en unknown
-
1999
- 1999-03-30 NO NO19991559A patent/NO313457B1/en not_active IP Right Cessation
-
2000
- 2000-01-20 HK HK00100370A patent/HK1021637A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9606778A (en) | Cell adhesion inhibitors | |
| ATE215366T1 (en) | TOPICAL COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASES | |
| MX9102209A (en) | DERIVATIVES OF NEW HYDROXAMIC ACID AND N-HYDROXYUREA AND ITS USE. | |
| SG124234A1 (en) | Cell adhesion inhibitors | |
| EA199800119A1 (en) | CELL ADHESION INHIBITORS | |
| NZ523957A (en) | 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent | |
| CA2200707A1 (en) | Novel prostaglandin synthase inhibitors | |
| EP1017382A4 (en) | Biarylalkanoic acids as cell adhesion inhibitors | |
| EA199800694A1 (en) | COMPOSITION INCLUDING IL-1 INHIBITOR AND HYDROGEL ETHER, AND METHODS OF ITS APPLICATION | |
| EA200100732A1 (en) | ANTI-INFLAMMATORY AND IMMUNOSUPRESSOR COMPOUNDS INHIBITING CELLULAR ADHESION | |
| FR2431505A1 (en) | NOVEL N- (DIAMINOPHOSPHINYL) ARYLCARBOXAMIDES, USEFUL IN PARTICULAR AS UREASE INHIBITORS | |
| MXPA02011858A (en) | Inhibitors of alpha l beta 2 mediated cell adhesion. | |
| TR199900725T2 (en) | Hydroxamic acid derivatives | |
| ATE31300T1 (en) | IMIDAZOLE-2-YL-MERCAPTOALKANIC ACIDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM. | |
| FR2430232A1 (en) | NOVEL ARYLAMINOBENZOIC ACIDS USEFUL IN PARTICULAR AS HYPOGLYCEMATING AGENTS | |
| BR0309135A (en) | Hydroxamic acid derivatives | |
| AU2068895A (en) | Dl- di- or tri-hydroxyphenylglycine alkyl esters for the treatment of inflammatory and allergic conditions | |
| DK372884D0 (en) | VALEPOTRIATE HYDRAINE FOR USE IN PHARMACEUTICALS | |
| FR2401158A1 (en) | NEWS 3- (4-CHROMANYLAMINO) -2-OXAZOLIDINONES USEFUL IN PARTICULAR AS INHIBITORS OF GASTRIC SECRETION | |
| CA2073673A1 (en) | Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors |